• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫原浆朊酶:不只是普通的古老降解胃蛋白酶。

Malaria parasite plasmepsins: More than just plain old degradative pepsins.

机构信息

Division of Infectious Diseases, Departments of Medicine and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.

Division of Infectious Diseases, Departments of Medicine and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA

出版信息

J Biol Chem. 2020 Jun 19;295(25):8425-8441. doi: 10.1074/jbc.REV120.009309. Epub 2020 May 4.

DOI:10.1074/jbc.REV120.009309
PMID:32366462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7307202/
Abstract

Plasmepsins are a group of diverse aspartic proteases in the malaria parasite Their functions are strikingly multifaceted, ranging from hemoglobin degradation to secretory organelle protein processing for egress, invasion, and effector export. Some, particularly the digestive vacuole plasmepsins, have been extensively characterized, whereas others, such as the transmission-stage plasmepsins, are minimally understood. Some ( plasmepsin V) have exquisite cleavage sequence specificity; others are fairly promiscuous. Some have canonical pepsin-like aspartic protease features, whereas others have unusual attributes, including the nepenthesin loop of plasmepsin V and a histidine in place of a catalytic aspartate in plasmepsin III. We have learned much about the functioning of these enzymes, but more remains to be discovered about their cellular roles and even their mechanisms of action. Their importance in many key aspects of parasite biology makes them intriguing targets for antimalarial chemotherapy. Further consideration of their characteristics suggests that some are more viable drug targets than others. Indeed, inhibitors of invasion and egress offer hope for a desperately needed new drug to combat this nefarious organism.

摘要

疟原虫中的裂殖体蛋白是一组多样化的天冬氨酸蛋白酶。其功能多种多样,从血红蛋白降解到分泌细胞器蛋白加工,涉及外排、入侵和效应物输出。其中一些,特别是消化液泡裂殖体蛋白,已经得到了广泛的研究,而其他一些,如传播阶段裂殖体蛋白,了解甚少。有些(裂殖体蛋白 V)具有精细的切割序列特异性;而其他的则相当混杂。有些具有典型的胃蛋白酶样天冬氨酸蛋白酶特征,而其他的则具有不寻常的属性,包括裂殖体蛋白 V 的 Nepenthesin 环和裂殖体蛋白 III 中的组氨酸取代了催化天冬氨酸。我们已经了解了这些酶的功能,但它们在细胞中的作用,甚至它们的作用机制,仍有许多有待发现。它们在寄生虫生物学的许多关键方面都很重要,因此成为抗疟化疗的有趣靶点。进一步考虑它们的特征表明,有些比其他的更适合作为药物靶点。事实上,入侵和外排抑制剂为对抗这种恶性生物提供了一种急需的新药的希望。

相似文献

1
Malaria parasite plasmepsins: More than just plain old degradative pepsins.疟原虫原浆朊酶:不只是普通的古老降解胃蛋白酶。
J Biol Chem. 2020 Jun 19;295(25):8425-8441. doi: 10.1074/jbc.REV120.009309. Epub 2020 May 4.
2
Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.近期在疟原虫蛋白酶药物化学方面的进展及其对未来抗疟药物研发工作的影响。
Curr Top Med Chem. 2012;12(5):445-55. doi: 10.2174/156802612799362959.
3
Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.疟原虫蛋白酶IX和X是疟原虫逸出和入侵的必需且可成药的介质。
Science. 2017 Oct 27;358(6362):518-522. doi: 10.1126/science.aan1478.
4
Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.来自啮齿动物疟原虫伯氏疟原虫的重组食物泡组织蛋白酶4的酶学特性分析
PLoS One. 2015 Oct 28;10(10):e0141758. doi: 10.1371/journal.pone.0141758. eCollection 2015.
5
QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.青蒿素衍生物的定量构效关系、对接和药物代谢动力学研究,针对疟原虫血红蛋白降解酶 Plasmepsin II 的抗疟活性。
Curr Pharm Des. 2012;18(37):6133-54. doi: 10.2174/138161212803582397.
6
New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.旧靶点的新范式:疟原虫天冬氨酸蛋白酶II的结构生物学及药物设计的最新进展
Eur J Med Chem. 2015 May 5;95:324-48. doi: 10.1016/j.ejmech.2015.03.049. Epub 2015 Mar 21.
7
Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.恶性疟原虫消化液泡中天冬氨酸蛋白酶——疟原虫蛋白酶I和II的动力学分析
Mol Biochem Parasitol. 1996 Jul;79(1):71-8. doi: 10.1016/0166-6851(96)02651-5.
8
Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II.疟疾天冬氨酸血红蛋白酶(疟原虫天冬氨酸蛋白酶 I 和 II)的生物合成与成熟
J Biol Chem. 1997 Jun 6;272(23):14961-8. doi: 10.1074/jbc.272.23.14961.
9
The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function.疟原虫天冬氨酸蛋白酶原朊酶 V 中的 nepenthesin 插入是酶功能所必需的。
J Biol Chem. 2022 Sep;298(9):102355. doi: 10.1016/j.jbc.2022.102355. Epub 2022 Aug 9.
10
Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).过去十年(2002-2012 年)疟原虫蛋白酶抑制剂的研究进展。
Curr Med Chem. 2013;20(25):3049-68. doi: 10.2174/0929867311320250003.

引用本文的文献

1
Aspartyl protease inhibition interferes with Plasmodium falciparum asexual blood-stage and early gametocyte development.天冬氨酸蛋白酶抑制作用会干扰恶性疟原虫无性血液期和早期配子体的发育。
Malar J. 2025 Aug 21;24(1):271. doi: 10.1186/s12936-025-05518-z.
2
Prevalence of Plasmodium falciparum plasmepsin2/3 gene duplication in Africa and Asia: a systematic review and meta-analysis.非洲和亚洲恶性疟原虫天冬氨酸蛋白酶2/3基因重复的流行情况:一项系统评价和荟萃分析。
Malar J. 2025 Aug 19;24(1):266. doi: 10.1186/s12936-025-05423-5.
3
Computational analysis of luteolin, apigenin and their derivatives from Allophylus africanus as potential inhibitors of plasmepsin II a malaria target.非洲异木患中木犀草素、芹菜素及其衍生物作为疟原虫靶点——疟原虫天冬氨酸蛋白酶II潜在抑制剂的计算分析
BMC Chem. 2025 Jul 3;19(1):196. doi: 10.1186/s13065-025-01527-w.
4
Identification of a large anion channel required for digestive vacuole acidification and amino acid export in Plasmodium falciparum.恶性疟原虫消化泡酸化和氨基酸输出所需的一种大型阴离子通道的鉴定。
PLoS Biol. 2025 May 30;23(5):e3003202. doi: 10.1371/journal.pbio.3003202. eCollection 2025 May.
5
Redox Homeostasis within the Drug-Resistant Malarial Parasite Digestive Vacuole.耐药疟原虫消化泡内的氧化还原稳态
Biochemistry. 2025 May 20;64(10):2247-2261. doi: 10.1021/acs.biochem.4c00750. Epub 2025 May 1.
6
Computer aided study on cyclic tetrapeptide based ligands as potential inhibitors of Proplasmepsin IV.基于环四肽的配体作为原质蛋白酶IV潜在抑制剂的计算机辅助研究
Sci Rep. 2025 Apr 22;15(1):13865. doi: 10.1038/s41598-025-96410-y.
7
Malaria parasite cysteine and aspartic proteases as key drug targets for antimalarial therapy.疟原虫半胱氨酸和天冬氨酸蛋白酶作为抗疟治疗的关键药物靶点。
J Mol Model. 2025 Feb 8;31(3):78. doi: 10.1007/s00894-025-06303-0.
8
Artemisinin-resistant Plasmodium falciparum Kelch13 mutant proteins display reduced heme-binding affinity and decreased artemisinin activation.对青蒿素耐药的恶性疟原虫 Kelch13 突变蛋白表现出降低的血红素结合亲和力和降低的青蒿素激活作用。
Commun Biol. 2024 Nov 13;7(1):1499. doi: 10.1038/s42003-024-07178-2.
9
To quest new targets of parasite and their potential inhibitors to combat antimalarial drug resistance.探寻疟原虫的新靶点及其对抗疟药耐药性的潜在抑制剂。
J Parasit Dis. 2024 Dec;48(4):671-722. doi: 10.1007/s12639-024-01687-x. Epub 2024 May 31.
10
Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks".肽-烷氧基胺药物:对抗血吸虫病的创新方法:“以叉掘墓”
Pathogens. 2024 Jun 6;13(6):482. doi: 10.3390/pathogens13060482.

本文引用的文献

1
Egress and invasion machinery of malaria: an in-depth look into the structural and functional features of the flap dynamics of plasmepsin IX and X.疟疾的逸出和入侵机制:深入探究疟原虫天冬氨酸蛋白酶IX和X的瓣动态结构与功能特征
RSC Adv. 2018 Jun 13;8(39):21829-21840. doi: 10.1039/c8ra04360d.
2
Contacting domains segregate a lipid transporter from a solute transporter in the malarial host-parasite interface.与质膜接触的结构域将脂质转运蛋白从疟原虫宿主-寄生虫界面的溶质转运蛋白中隔离出来。
Nat Commun. 2020 Jul 30;11(1):3825. doi: 10.1038/s41467-020-17506-9.
3
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.双重靶向疟原虫蛋白酶的抗疟药物破坏疟原虫生命周期的多个阶段。
Cell Host Microbe. 2020 Apr 8;27(4):642-658.e12. doi: 10.1016/j.chom.2020.02.005. Epub 2020 Feb 27.
4
An Endoplasmic Reticulum CREC Family Protein Regulates the Egress Proteolytic Cascade in Malaria Parasites.内质网 CREC 家族蛋白调控疟原虫出芽蛋白酶级联反应。
mBio. 2020 Feb 25;11(1):e03078-19. doi: 10.1128/mBio.03078-19.
5
Assessment of Biological Role and Insight into Druggability of the Protease Plasmepsin V.评估蛋白酶 Plasmepsin V 的生物学作用及可成药性研究。
ACS Infect Dis. 2020 Apr 10;6(4):738-746. doi: 10.1021/acsinfecdis.9b00460. Epub 2020 Feb 27.
6
EXP1 is required for organisation of EXP2 in the intraerythrocytic malaria parasite vacuole.EXP1 对于疟原虫内的 EXP2 空泡的形成是必需的。
Cell Microbiol. 2020 May;22(5):e13168. doi: 10.1111/cmi.13168. Epub 2020 Feb 12.
7
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present).疟原虫属蛋白酶抑制剂在抗疟药物研发中的应用:药物化学和靶点确证(2000 年至今)。
J Med Chem. 2020 May 14;63(9):4445-4467. doi: 10.1021/acs.jmedchem.9b01622. Epub 2020 Jan 23.
8
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.Kelch13 定义的内吞途径介导疟原虫对青蒿素的耐药性。
Science. 2020 Jan 3;367(6473):51-59. doi: 10.1126/science.aax4735.
9
Inhibition of Plasmepsin V Activity Blocks Plasmodium falciparum Gametocytogenesis and Transmission to Mosquitoes.抑制疟原虫裂殖子 V 活性可阻断疟原虫配子体形成和向蚊子传播。
Cell Rep. 2019 Dec 17;29(12):3796-3806.e4. doi: 10.1016/j.celrep.2019.11.073.
10
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance.疟原虫 K13 丰度降低可减少血红蛋白代谢和蛋白毒性应激,为青蒿素耐药提供了基础。
Cell Rep. 2019 Nov 26;29(9):2917-2928.e5. doi: 10.1016/j.celrep.2019.10.095.